Acquired
Novo Nordisk (Ozempic)
David Rosenthal
So that's 2005. So then in 2007, Lata and Novo Nordisk's liraglutide GLP-1 agonist enters phase three human clinical trials.
0
💬
0
Comments
Log in to comment.
There are no comments yet.